Diagnostic accuracy of microalbuminuria in secondary nephropathies

Authors

  • I. Kostovska Department of Medical and Experimental Biochemistry, Faculty of Medicine, Ss Cyril and Methodius University – Skopje, North Macedonia Author https://orcid.org/0000-0003-0971-6710
  • K. Trajkovska Department of Medical and Experimental Biochemistry, Faculty of Medicine, Ss Cyril and Methodius University – Skopje, North Macedonia Author
  • D. Labudovic Department of Medical and Experimental Biochemistry, Faculty of Medicine, Ss Cyril and Methodius University – Skopje, North Macedonia Author
  • S. Cekovska Department of Medical and Experimental Biochemistry, Faculty of Medicine, Ss Cyril and Methodius University – Skopje, North Macedonia Author
  • O. Kostovski Department of Digestive Surgery, Faculty of Medicine, Ss Cyril and Methodius University – Skopje, North Macedonia Author
  • G. Spasovski Department of Nephrology, Faculty of Medicine, Ss Cyril and Methodius University – Skopje, North Macedonia Author

DOI:

https://doi.org/10.2478/AMB-2024-0049

Keywords:

diagnostic accuracy, ROC, urinary microalbumin to creatinine ratio, diabetic nephropathy, hypertensive nephropathy, pre-eclampsia

Abstract

Introduction: Microalbuminuria is an initial indicator of kidney damage in diabetic nephropathy (DN), hypertensive nephropathy (HN), and pre-eclampsia (PE). This study aims to assess the diagnostic accuracy of urinary microalbumin to creatinine ratio 
(UM/CR) as an early diagnostic tool in patients with DN, HN, and PE. Materials and methods: In this cross-sectional study, we included a total of 143 subjects divided into three groups: first-group patients with DN (n = 30), second-group patients with HN (n = 23), and 
third-group women with PE (n = 30). Additionally, we included a control group comprising 60 healthy subjects. The study employed fresh urine samples to measure UM/CR by the turbidimetric method and creatinine by the Jaffe reaction. We also estimated the UM/CR and glomerular filtration rate. Some biochemical parameters were measured in blood sera. Results: We determined the cut-off value of UM/CR to be 30.0 mg/g. For patients with DN, UM/CR had a sensitivity of 41.5%, a specificity of 90%, and an overall diagnostic accuracy of 53.1% for detecting DN. Similarly, for patients with HN, UM/CR had a sensitivity of 44.8% and a specificity of 86.1%, with an overall diagnostic accuracy of 57.8% for detecting HN. In contrast, for women with PE, UM/CR had a sensitivity of 100%, a specificity of 93.3%, and a diagnostic accuracy of 96.7% for predicting PE. Conclusion: UM/CR can be used as a good screening tool for early detection of PE, while it has low sensitivity as an early marker for patients with DN and HN.

References

Prasad RM, Bali A, Tikaria R. Microalbuminuria. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Sana MA, Chaudhry M, Malik A, et al. Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus. Cureus, 2020;12(12):e12318.

Patel S, Savlani P. Microalbuminuria in essential hypertension: A single-center study. IP J Diagn Pathol Oncol, 2021;6(3):189-193.

Amin R, Ahn S, Moudgil A. Kidney and urinary tract disorders. In Dietzen D, Bennett M, Wong E, Haymond S, eds. Biochemical

and molecular basis of pediatric disease. Massachusetts. Elservier, Academic Press, 2021(5th ed), p.557.

Rupakala BM, Sudha GS, Lakshmi SMPA. Microalbuminuria and spot protein creatinine ratio in early pregnancy as a predictor of pre-eclampsia. Int J Reprod Contracept Obstet Gynecol, 2021;10:1452-1456.

Thipsawat S. Early detection of diabetic nephropathy in a patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res, 2021;18(6):14791641211058856.

Jagroop S, Manpreet K. Int J Sci Res Sci and Technol, 2021;8(4):274-279.

Asma BK, Firoza B, Sumaiya A, et al. Microalbuminuria in early pregnancy as a Predictor of Pre-eclampsia. Sch Int J Obstet Gynec, 2022;5(2):37-42.

Kapoula GV, Kontou PI, Bagos PG. Diagnostic Performance of Biomarkers Urinary KIM-1 and YKL-40 for Early Diabetic Nephropathy, in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diagnostics (Basel), 2020;10(11):909.

Zhang J, Liu J, Qin X. Advances in early biomarkers of diabetic nephropathy. Rev Assoc Med Bras, 2018;64(1):85-92.

Rico-Fontalvo J, Aroca-Martínez G, Daza-Arnedo R, et al. Novel Biomarkers of Diabetic Kidney Disease. Biomolecules, 2023;13(4):633.

Mironova SA, Zvartau NE, Konradi AO. Kidney injury in arterial hypertension: can we trust the old markers? Arterial Hypertension, 2016;22(6):536-550.

Bezrodna L, Mishchenko L, Serbenjuk K, et al. Early markers of the kidney damage in patients with resistant hypertension. Journal of Hypertension, 2022;40(1):p e254-e255.

Danielli M, Thomas RC, Gillies CL, et al. Blood biomarkers to predict the onset of pre-eclampsia: A systematic review and meta-analysis. Heliyon, 2022;8(11):e11226.

Kenny LC, Thomas G, Poston L, et al. Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test. PLoS One, 2020;15(12):e0244369.

Lipsombe L, Booth G, Butalia S, et al. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Pharmacologic Glycemic Management of Type 2 Diabetes in Adults. Can J Diabetes, 2018;42(1):S88-S103.

Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA, 2019;322(13):1294-1304.

Gestational Hypertension and Pre-eclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol, 2020;135:e237.

Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011), 2013;3(1):19-62. 20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 1976;16(1):31-41.

Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol, 2022;75(1):25-36.

Cheng W, CuiCui L, WenYu G, Tanqi L. New urinary biomarkers for diabetic kidney disease. Biomark Res, 2013;1-9.

Salako BL, Olayemi O, Odukogbe AT, et al. Microalbuminuria in pregnancy as a predictor of pre-eclampsia and eclampsia. West Afr J Med, 2003;22(4):295-300.

Zen M, Padmanabhan S, Cheung NW, et al. Microalbuminuria as an early predictor of pre-eclampsia in the pre-gestational diabetic population: A prospective cohort study. Pregnancy Hypertens, 2019;15:182-188.

Wong H, Lim, G. Measures of Diagnostic Accuracy: Sensitivity, Specificity, PPV and NPV. Proceedings of Singapore Healthcare, 2011;20(4):316-318.

Sampaio E, Delfino VD. Assessing albuminuria in spot morning samples from diabetic patients. Arq Bras Endocrinol Metabol, 008;52(9):1482-8.

Johns KW, Robinson CE, Wilson IM, et al. Does the albumin:creatinine ratio lack clinical utility in predicting microalbuminuria? BCMJ, 2006;48(8):399-403.

Teimoury A, Iraj B, Heidari‑Beni M, et al. Why 24‑h urine albumin excretion rate method still is used for screening of diabetic nephropathy in Isfahan laboratories?. Int J Prev Med, 2014;5:341-347.

Manjappa AA, Sivapragasam V, Mohan T. Spot Urinary Albumin–Creatinine Ratio in Prediction of Pre-eclampsia: A Prospective Study. J South Asian Feder Obst Gynae, 2022;14(6):676-680.

Downloads

Published

04.10.2024

How to Cite

Kostovska, I., Trajkovska, K., Labudovic, D., Cekovska, S., Kostovski, O., & Spasovski, G. (2024). Diagnostic accuracy of microalbuminuria in secondary nephropathies. Acta Medica Bulgarica, 51(Suppl 2), 24-28. https://doi.org/10.2478/AMB-2024-0049